2024 Hyundai Kona SEL
2.0 L • 4 • FWD • AT
KM8HC3AB7RU160163
Sales history: 14
Highlights
Condition
Not provided
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Bad
History
14 records
Drive
2.0 L • 4 • FWD • AT
Odometer
258 mi ≈ 415 km
Primary damage
Biohazard chemical
Secondary damage
Rollover
Docs
TN • Non-Repair Cert
Extra
Auction
VIN
KM8HC3AB7RU160163
Lot number
78401674
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Nashville, TN
Description
Fuel type
Gasoline
Body color
Charcoal
Body type
SUV
Generation
SX2
Trim
SEL
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2024 Hyundai Kona SEL • 2.0 L • 4 cyl • FWD • Automatic • Copart Lot: 78401674 • VIN: KM8HC3AB7RU160163
Find out more about this 2024 Hyundai Kona SEL, available at the Copart salvage car auction as lot #78401674 in Nashville, TN. This car has Biohazard chemical main damage. It is listed with start condition code. Odometer shows 258 mi. This Charcoal Hyundai Kona SUV is equipped with Gasoline 2.0 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KM8HC3AB7RU160163 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
